Actively Recruiting
A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain
Led by Montefiore Medical Center · Updated on 2026-04-23
110
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
Sponsors
M
Montefiore Medical Center
Lead Sponsor
P
Pacira Pharmaceuticals, Inc
Collaborating Sponsor
AI-Summary
What this Trial Is About
A research study is being conducted to compare two treatments for long-term low back pain: * One uses the iovera° system, which applies cold to certain nerves in the lower back. * The other is the standard treatment called radiofrequency ablation, which uses heat. The primary objective is to find out which treatment works better to reduce back pain. Participants in this study will be randomly placed in one of the two treatment groups. The clinical research team will check on participant pain levels and overall health before and after the procedure for about 12 months. The entire study will last about 14 months for each participant.
CONDITIONS
Official Title
A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old at screening
- Primary axial low-back pain suggesting bilateral facet joint involvement confirmed by provocative tests
- Chronic low back pain lasting 3 months or more
- Moderate to severe low back pain with a numeric rating score between 5 and 9 at screening
- Functional impairment with at least 30% disability on the Oswestry Disability Index at screening
- Two successful diagnostic medial branch blocks with local anesthetic only showing at least 80% pain relief
- Failed at least three months of conservative non-operative therapy such as physical therapy, chiropractic care, or analgesics
- Able to consent, follow study visits, and complete assessments
You will not qualify if you...
- Active workers' compensation, personal injury, disability insurance, or litigation related to the spine
- Serious spinal disorders including suspected cauda equina syndrome, infection, tumor, fracture, systemic inflammatory spondyloarthropathy, lumbar radiculopathy, neurogenic claudication, or prior lumbar fusion at treatment levels
- Comorbidities affecting participation such as lumbar radiculopathy or neuropathic pain disorder
- Currently pregnant, nursing, or planning pregnancy during the study
- Known contraindications to study device including cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud's disease, infected wounds near treatment site, or coagulopathy
- Severe chronic pain disorder impacting outcomes
- Presence of spinal neurostimulator, intrathecal analgesic pump, or cardiac implantable device
- Poorly controlled mental illness or catastrophizing impacting outcomes, including mood disorders with PHQ-9 score 12 or higher, psychotic disorders, or PCS score over 30
- Spine interventions within 30 days prior to block administration
- Radiofrequency ablation in low back within 6 months prior to enrollment
- Pain relief from diagnostic medial branch blocks lasting longer than local anesthetic duration
- History or suspicion of alcohol or illicit drug abuse
- Opioid dependence exceeding 40 mg per day in past 30 days
- Not medically fit or cleared for surgery due to COVID-19 or other serious illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Montefiore Multidisciplinary Pain Program
The Bronx, New York, United States, 10461
Actively Recruiting
Research Team
K
Karina Gritsenko, MD
CONTACT
R
Rafi Khandaker, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here